Nuwellis Inc vs Omnicom Group Inc. — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Omnicom Group Inc. trades at $78.55 (market cap $22.26B). The key difference: Omnicom Group Inc. is far larger — about 8904× Nuwellis Inc's market cap, and Omnicom Group Inc. pays a 3.94% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | OMC | |
|---|---|---|
Market Cap | $2.50M | $22.26B |
Sector | Technology | Media |
52-Week High | $164.50 | $88.94 |
52-Week Low | $0.73 | $67.27 |
Enterprise Value | -$1.21M | $30.33B |
Dividend Yield | — | 3.94% |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Omnicom Group (OMC) trades at $81.13, down 1.8% on the day, with a bearish technical outlook and mixed quarterly earnings performance. The company reported strong revenue growth to $17.27 billion in 2025 but posted a net loss of $54.5 million due to acquisition costs. Analyst consensus remains cautious with a 'Hold' rating despite a $96.50 price target representing 19% upside potential. Recent leadership transitions and media agency consolidation signal strategic repositioning amid challenging market conditions.
OMC presents a value opportunity with attractive valuation multiples (P/S: 0.91x, P/B: 2.3x) and a 4% dividend yield, but faces integration risks from the Interpublic acquisition and margin pressure. The stock's near-term trajectory depends on successful cost synergies and organic growth acceleration beyond current 6.1% levels. Debt levels have increased substantially post-acquisition, requiring careful monitoring of cash flow generation.
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →